CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 121 filers reported holding CYTOMX THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $28,000 | -95.9% | 10,528 | -93.3% | 0.00% | – |
Q4 2021 | $682,000 | +20.9% | 157,460 | +42.0% | 0.00% | – |
Q3 2021 | $564,000 | -29.7% | 110,853 | -12.6% | 0.00% | – |
Q2 2021 | $802,000 | -24.5% | 126,781 | -7.7% | 0.00% | -100.0% |
Q1 2021 | $1,062,000 | +80.3% | 137,304 | +52.5% | 0.00% | – |
Q4 2020 | $589,000 | +199.0% | 90,014 | +204.7% | 0.00% | – |
Q3 2020 | $197,000 | -31.8% | 29,540 | -14.8% | 0.00% | – |
Q2 2020 | $289,000 | +61.5% | 34,662 | +48.3% | 0.00% | – |
Q1 2020 | $179,000 | -60.4% | 23,367 | -57.0% | 0.00% | – |
Q4 2019 | $452,000 | +130.6% | 54,293 | +104.7% | 0.00% | – |
Q3 2019 | $196,000 | -50.6% | 26,519 | -24.9% | 0.00% | – |
Q2 2019 | $397,000 | -8.5% | 35,328 | -12.5% | 0.00% | – |
Q1 2019 | $434,000 | +1569.2% | 40,382 | +2275.4% | 0.00% | – |
Q4 2018 | $26,000 | -91.9% | 1,700 | -90.2% | 0.00% | – |
Q3 2018 | $321,000 | -21.9% | 17,322 | -3.7% | 0.00% | – |
Q2 2018 | $411,000 | -10.1% | 17,989 | +12.2% | 0.00% | – |
Q1 2018 | $457,000 | +3.6% | 16,032 | -23.2% | 0.00% | – |
Q4 2017 | $441,000 | -11.3% | 20,870 | -23.8% | 0.00% | -100.0% |
Q3 2017 | $497,000 | +250.0% | 27,386 | +199.3% | 0.00% | – |
Q2 2017 | $142,000 | -35.7% | 9,151 | -28.6% | 0.00% | – |
Q1 2017 | $221,000 | +7266.7% | 12,820 | +5498.3% | 0.00% | – |
Q4 2016 | $3,000 | -40.0% | 229 | -34.4% | 0.00% | – |
Q3 2016 | $5,000 | +66.7% | 349 | +109.0% | 0.00% | – |
Q4 2015 | $3,000 | – | 167 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Burrage Capital Management LLC | 476,110 | $3,956,000 | 2.65% |
MPM BioImpact LLC | 855,437 | $7,109,000 | 2.52% |
Exane Asset Management | 87,876 | $730,250,000 | 0.90% |
Congress Park Capital LLC | 94,661 | $787,000 | 0.58% |
Perceptive Advisors | 3,253,923 | $27,040,000 | 0.54% |
BVF INC/IL | 766,148 | $6,367,000 | 0.48% |
RTW INVESTMENTS, LP | 1,039,593 | $8,639,000 | 0.33% |
EcoR1 Capital, LLC | 410,000 | $3,407,000 | 0.31% |
DAFNA Capital Management LLC | 100,000 | $831,000 | 0.28% |
HARBOURVEST PARTNERS LLC | 79,193 | $658,000 | 0.27% |